PL2301532T3 - Zastosowanie statyn jako środków przeciwdrgawkowych, przeciwpadaczkowych oraz neuroprotekcyjnych - Google Patents

Zastosowanie statyn jako środków przeciwdrgawkowych, przeciwpadaczkowych oraz neuroprotekcyjnych

Info

Publication number
PL2301532T3
PL2301532T3 PL09757654T PL09757654T PL2301532T3 PL 2301532 T3 PL2301532 T3 PL 2301532T3 PL 09757654 T PL09757654 T PL 09757654T PL 09757654 T PL09757654 T PL 09757654T PL 2301532 T3 PL2301532 T3 PL 2301532T3
Authority
PL
Poland
Prior art keywords
neuroprotectors
antiepileptics
anticonvulsants
statins
Prior art date
Application number
PL09757654T
Other languages
English (en)
Inventor
Muñoz Javier Santos Burgos
Moreno Carlos Ramírez
Alvarez Javier Velasco
Original Assignee
Neuron Biopharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuron Biopharma Sa filed Critical Neuron Biopharma Sa
Publication of PL2301532T3 publication Critical patent/PL2301532T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09757654T 2008-06-03 2009-06-03 Zastosowanie statyn jako środków przeciwdrgawkowych, przeciwpadaczkowych oraz neuroprotekcyjnych PL2301532T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200801733A ES2330184B1 (es) 2008-06-03 2008-06-03 Uso de estatinas como anticonvulsivantes, antiepilepticos y neuroprotectores.
EP09757654.0A EP2301532B1 (en) 2008-06-03 2009-06-03 Use of statins as anticonvulsants, antiepileptics and neuroprotectors
PCT/ES2009/070201 WO2009147275A1 (es) 2008-06-03 2009-06-03 Uso de estatinas como anticonvulsivantes, antiepilépticos y neuroprotectores

Publications (1)

Publication Number Publication Date
PL2301532T3 true PL2301532T3 (pl) 2015-04-30

Family

ID=41328842

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09757654T PL2301532T3 (pl) 2008-06-03 2009-06-03 Zastosowanie statyn jako środków przeciwdrgawkowych, przeciwpadaczkowych oraz neuroprotekcyjnych

Country Status (7)

Country Link
US (1) US8927599B2 (pl)
EP (1) EP2301532B1 (pl)
DK (1) DK2301532T3 (pl)
ES (2) ES2330184B1 (pl)
PL (1) PL2301532T3 (pl)
PT (1) PT2301532E (pl)
WO (1) WO2009147275A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2344826B1 (es) * 2009-03-06 2011-06-06 Neuron Biopharma, S.A. Compuestos neuroprotectores.
ES2380473B1 (es) * 2010-10-13 2013-02-19 Neuron Biopharma, S.A. Compuesto neuroprotector, hipocolesterolémico, antiinflamatorio y antiepiléptico.
WO2012054724A1 (en) * 2010-10-21 2012-04-26 Massachusetts Institute Of Technology Methods of treating seizure disorders
WO2014210538A1 (en) * 2013-06-28 2014-12-31 The Regents Of The University Of California Treating cognitive deficits associated with noonan syndrome

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (pl) 1974-06-07 1981-03-18
US4231938A (en) 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
AU548996B2 (en) 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
DK149080C (da) 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
AU570021B2 (en) 1982-11-22 1988-03-03 Novartis Ag Analogs of mevalolactone
NO177005C (no) 1988-01-20 1995-07-05 Bayer Ag Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US6080778A (en) * 1998-03-23 2000-06-27 Children's Medical Center Corporation Methods for decreasing beta amyloid protein
US6472421B1 (en) * 1998-11-13 2002-10-29 Nymox Corporation Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor
US7323496B2 (en) * 1999-11-08 2008-01-29 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
US8519005B2 (en) * 2000-07-27 2013-08-27 Thomas N. Thomas Compositions and methods to prevent toxicity of antiinflammatory agents and enhance their efficacy
AU2004308966A1 (en) * 2003-12-23 2005-07-14 Musc Foundaton For Research Development Methods and compositions for the prevention and treatment of inflammatory diseases or conditions
DE602005008935D1 (de) * 2004-04-26 2008-09-25 Alcon Inc Statine zur behandlung von okularer hypertonie und glaukom
CA2640615A1 (en) * 2006-01-30 2007-08-09 Israel Ben David Bryson Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients

Also Published As

Publication number Publication date
ES2330184A1 (es) 2009-12-04
ES2330184B1 (es) 2010-07-05
ES2528212T3 (es) 2015-02-05
US8927599B2 (en) 2015-01-06
EP2301532A1 (en) 2011-03-30
US20110184056A1 (en) 2011-07-28
EP2301532B1 (en) 2014-10-29
WO2009147275A1 (es) 2009-12-10
EP2301532A4 (en) 2013-01-23
PT2301532E (pt) 2015-02-04
DK2301532T3 (en) 2015-01-12

Similar Documents

Publication Publication Date Title
IL210804A (en) Benzylidenehydrazides and their uses
ZA201103515B (en) Composition comprising polymer and enzyme
IL254218A0 (en) Pipedrine-bridged compounds of the quinoxaline-converted type and their use
IL211042A0 (en) Imidazopyridin-2-one derivatives and uses thereof
ZA201005506B (en) Oligopeptidic compounds and uses thereof
ZA201103635B (en) Azaquinolinone derivatives and uses thereof
GB0808575D0 (en) Compilign and linking
EP2291377A4 (en) IMIDAZOPYRIMIDINONE AND ITS USES
ZA201103456B (en) Leukolectins and uses thereof
EP2247601A4 (en) THIAZOPYRIMIDINONE AND APPLICATIONS THEREOF
IL202722A0 (en) 4-imidazolines and their use as antidepressants
PT2301532E (pt) Utilização de estatinas como anticonvulsivantes, antiepilépticos e neuroprotectores
ZA201000357B (en) 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
TWI367210B (en) Estrogenic-active compounds and application thereof
PL2376479T3 (pl) Podstawione furanokarboksyamidy i ich zastosowanie
GB0813359D0 (en) Halfin and/or platerfin
IL206951A0 (en) 3-alkyl-piperazine derivatives and uses thereof
GB0808857D0 (en) Methdos and uses
AP2675A (en) The distrubution of eletricity
HU0800405D0 (en) Ewnvironment-friendly biocidis and use thereof
GB0810609D0 (en) Methods and uses
GB0816523D0 (en) Methods and uses
GB0907720D0 (en) Bouquets and posies
IL206950A0 (en) Aminopiperidinyl derivatives and uses thereof